Delivery Order SPE2DB24D2100-SPE2DB25FBCFK

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.12 firm fixed-price delivery order is for the supply of ESTROGEL 0.06% GEL 50GM, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ESTROGEL 0.06% GEL 37.5GM. The firm-fixed-price delivery order, valued at $1,079.16, has a completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.66 firm fixed-price delivery order is for the supply of ESTROGEL 0.06% GEL 50GM, a topical medication. The award has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,680.02 delivery order provides the DLA with a variety of pharmaceutical products and medical supplies, including ESTROGEL 0.06% GEL 50GM. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of ESTROGEL 0.06% GEL 37.5GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $3,331.54, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,331.54. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.22 firm fixed-price delivery order is for the supply of ESTRADIOL 0.06% 1.25G GEL PUMP 37.5GM, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,938.68, is for the delivery of Estradiol 0.06% 1.25G Gel Pump, 37.5GM. It is a firm-fixed-price delivery order contract with a completion date of January 24, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a larger $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of ESTROGEL 0.06% GEL 50GM, a pharmaceutical product, with a potential value of $1,080.59. The contract is a firm fixed price delivery order with a completion date of December 22, 2023. No set-aside designation was used for this award....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Estradiol 0.01% Cream, 42.5g, to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $15,774.09, is a firm fixed-price delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 and runs through December 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.12 firm-fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBCFK
    Delivery Order

This federal contract award, valued at $1,956.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEL 0.06% GEL 37.5GM, a medical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of February 18, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 11:56 AM